References
- Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7. https://doi.org/10.1016/S0140-6736(97)01004-0
- Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymphnode resection compared with conventional axillary-lymphnode dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11:927-33. https://doi.org/10.1016/S1470-2045(10)70207-2
- Veronesi U, Viale G, Paganelli G, et al. Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 2010;251:595-600. https://doi.org/10.1097/SLA.0b013e3181c0e92a
- Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006;98:599-609. https://doi.org/10.1093/jnci/djj158
- Straver ME, Meijnen P, van Tienhoven G, et al. Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol 2010;28:731-7. https://doi.org/10.1200/JCO.2008.21.7554
- Grube BJ, Giuliano AE. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 2001;20:230-7. https://doi.org/10.1002/ssu.1038
- Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial. Lancet Oncol 2013;14:297-305. https://doi.org/10.1016/S1470-2045(13)70035-4
- Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011;305:569-75. https://doi.org/10.1001/jama.2011.90
- Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 2010;252:426-33.
- Donker M, Straver ME, van Tienhoven G, et al. Comparison of the sentinel node procedure between patients with multifocal and unifocal breast cancer in the EORTC 10981-22023 AMAROS Trial: identification rate and nodal outcome. Eur J Cancer 2013;49:2093-100. https://doi.org/10.1016/j.ejca.2013.02.017
- Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401. https://doi.org/10.1097/00000658-199409000-00015
- Veronesi U, Galimberti V, Paganelli G, et al. Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer 2009;45:1381-8. https://doi.org/10.1016/j.ejca.2008.11.041
- Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 2009;27:2946-53. https://doi.org/10.1200/JCO.2008.19.5750
- Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004;240:462-71. https://doi.org/10.1097/01.sla.0000137130.23530.19
- van der Ploeg IM, Nieweg OE, van Rijk MC, Valdes Olmos RA, Kroon BB. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 2008;34:1277-84. https://doi.org/10.1016/j.ejso.2008.01.034
- Goodwin P. For patients with sentinel node-positive early breast cancer, RT as effective as and less toxic than complete surgical axillary clearance. Oncol Times 2013;35:33-4.
- Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Metaanalysis of sentinel lymph node biopsy in breast cancer. J Surg Res 1999;84:138-42. https://doi.org/10.1006/jsre.1999.5629
- Ban EJ, Lee JS, Koo JS, Park S, Kim SI, Park BW. How many sentinel lymph nodes are enough for accurate axillary staging in T1-2 breast cancer? J Breast Cancer 2011;14:296-300. https://doi.org/10.4048/jbc.2011.14.4.296
Cited by
- Simple Prediction Model of Axillary Lymph Node Positivity After Analyzing Molecular and Clinical Factors in Early Breast Cancer vol.95, pp.20, 2016, https://doi.org/10.1097/md.0000000000003689
- Complications and outcomes following inguinal lymphadenectomy for malignant melanoma in an Asian population vol.16, pp.2, 2014, https://doi.org/10.14216/kjco.20012